Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilon Health (AGL), MiMedx Group (MDXG) and Park Dental Partners, Inc. (PARK)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agilon Health (AGL – Research Report), MiMedx Group (MDXG – Research Report) and Park Dental Partners, Inc. (PARK – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Agilon Health (AGL)
Bank of America Securities analyst Michael Craig Jones maintained a Sell rating on Agilon Health today. The company’s shares closed last Thursday at $0.56.
According to TipRanks.com, Jones is ranked #3348 out of 12136 analysts.
Currently, the analyst consensus on Agilon Health is a Hold with an average price target of $0.84, implying a 69.7% upside from current levels. In a report released today, TipRanks – Google also downgraded the stock to Sell with a $0.47 price target.
See today’s best-performing stocks on TipRanks >>
MiMedx Group (MDXG)
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on MiMedx Group today. The company’s shares closed last Thursday at $4.87.
According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for MiMedx Group with a $9.60 average price target, implying an 83.2% upside from current levels. In a report issued on February 23, Citizens JMP also initiated coverage with a Buy rating on the stock with a $10.00 price target.
Park Dental Partners, Inc. (PARK)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Park Dental Partners, Inc.. The company’s shares closed last Thursday at $19.97, close to its 52-week high of $21.60.
According to TipRanks.com, Hewitt has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Park Dental Partners, Inc. with a $21.50 average price target.
